Identifying and reporting risk factors for adverse events in endoscopy. Part I: Cardiopulmonary events

Gastrointestinal Endoscopy

Volumn 73, Issue 3, 2011, Pages 579-585

  Romagnuolo, Joseph ^a   Cotton, Peter B ^a   Eisen, Glenn ^b   Vargo, John ^c   Petersen, Bret T ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Acute Physiology and Chronic Health Evaluation; adverse event; AE; American Society for Gastrointestinal Endoscopy; American Society of Anesthesiologists; APACHE; ASA; ASGE; CHF; chronic obstructive pulmonary disease; congestive heart failure; COPD; MET; metabolic equivalent; MI; myocardial infarction; National Surgical Quality Improvement Program; NSQIP; Physiologic and Operative Severity Score for the Enumeration of Mortality and Morbidity; POSSUM

Indexed keywords

ANGINA PECTORIS; ANTICOAGULANT THERAPY; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL RESEARCH; COLONOSCOPY; COMORBIDITY; CONFERENCE PAPER; DECISION MAKING; DIABETES MELLITUS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; ESOPHAGOGASTRODUODENOSCOPY; FUNCTIONAL STATUS; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPOTENSION; INFORMED CONSENT; PANCREATITIS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; STANDARDIZATION; STROKE; THORAX PAIN; VALVULAR HEART DISEASE;

CARDIOVASCULAR DISEASES; ENDOSCOPY; HUMANS; LUNG DISEASES; RISK ASSESSMENT; RISK FACTORS;

EID: 79952059774     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2010.11.022     Document Type: Conference Paper

References (39)

1. Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010;71:446-54.
2. Singh H, Poluha W, Cheung M, et al. Propofol for sedation during colonoscopy. Cochrane Database Syst Rev 2008;(4):CD006268.
3. Gangi S, Saidi F, Patel K, et al. Cardiovascular complications after GI endoscopy: occurrence and risks in a large hospital system. Gastrointest Endosc 2004;60:679-85. (Pubitemid 39550923)
4. Ross C, Frishman WH, Peterson SJ, et al. Cardiovascular considerations in patients undergoing gastrointestinal endoscopy. Cardiol Rev 2008;16:76-81. (Pubitemid 351278375)
5. Sharma VK, Nguyen CC, Crowell MD, et al. A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc 2007;66:27-34. (Pubitemid 46970757)
6. Vargo JJ, Holub JL, Faigel DO, et al. Risk factors for cardiopulmonary events during propofol-mediated upper endoscopy and colonoscopy. Aliment Pharmacol Ther 2006;24:955-63. (Pubitemid 44326376)
7. Qadeer MA, Vargo JJ, Khandwala F, et al. Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis. Clin Gastroenterol Hepatol 2005;3:1049-56. (Pubitemid 41565368)
8. Bini EJ, Firoozi B, Choung RJ, et al. Systematic evaluation of complications related to endoscopy in a training setting: a prospective 30-day outcomes study. Gastrointest Endosc 2003;57:8-16. (Pubitemid 36236792)
9. Steffes CP, Sugawa C, Wilson RF, et al. Oxygen saturation monitoring during endoscopy. Surg Endosc 1990;4:175-8.
10. Cappell MS, Iacovone FM Jr. Safety and efficacy of esophagogastroduodenoscopy after myocardial infarction. Am J Med 1999;106:29-35. (Pubitemid 29077139)
11. Spier BJ, Said A, Moncher K, et al. Safety of endoscopy after myocardial infarction based on cardiovascular risk categories: a retrospective analysis of 135 patients at a tertiary referral medical center. J Clin Gastroenterol 2007;41:462-7. (Pubitemid 46642532)
12. Cappell MS. Safety and clinical efficacy of flexible sigmoidoscopy and colonoscopy for gastrointestinal bleeding after myocardial infarction. A six-year study of 18 consecutive lower endoscopies at two university teaching hospitals. Dig Dis Sci 1994;39:473-80.
13. Cappell MS. Safety and efficacy of colonoscopy after myocardial infarction: an analysis of 100 study patients and 100 control patients at two tertiary cardiac referral hospitals. Gastrointest Endosc 2004;60:901-9. (Pubitemid 39655463)
14. Cote GA, Hovis RM, Ansstas MA, et al. Incidence of sedation-related complications with propofol use during advanced endoscopic procedures. Clin Gastroenterol Hepatol 2010;8:137-42.
15. Rex DK, Deenadayalu VP, Eid E, et al. Endoscopist-directed administration of propofol: a worldwide safety experience. Gastroenterology 2009;137:1229-37; quiz 1518-9.
16. Horiuchi A, Nakayama Y, Hidaka N, et al. Low-dose propofol sedation for diagnostic esophagogastroduodenoscopy: results in 10,662 adults. Am J Gastroenterol 2009;104:1650-5.
17. Khiani VS, Salah W, Maimone S, et al. Sedation during endoscopy for patients at risk of obstructive sleep apnea. Gastrointest Endosc 2009;70:1116-20.
18. Hillman DR, Loadsman JA, Platt PR, et al. Obstructive sleep apnoea and anaesthesia. Sleep Med Rev 2004;8:459-71. (Pubitemid 39539739)
19. Netzer NC, Stoohs RA, Netzer CM, et al. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999;131:485-91. (Pubitemid 29482391)
20. Qadeer MA, Rocio Lopez A, Dumot JA, et al. Risk factors for hypoxemia during ambulatory gastrointestinal endoscopy in ASA I-II patients. Dig Dis Sci 2009;54:1035-40.
21. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-51. (Pubitemid 24361532)
22. Copeland GP, Jones D, Wilcox A, et al. Comparative vascular audit using the POSSUM scoring system. Ann R Coll Surg Engl 1993;75:175-7. (Pubitemid 23149842)
23. Whiteley MS, Prytherch DR, Higgins B, et al. An evaluation of the POSSUM surgical scoring system. Br J Surg 1996;83:812-5. (Pubitemid 26175091)
24. Bann SD, Sarin S. Comparative audit: the trouble with POSSUM. J R Soc Med 2001;94:632-4. (Pubitemid 33151371)
25. Owens WD, Felts JA, Spitznagel EL Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology 1978;49:239-43. (Pubitemid 9032534)
26. Mak PH, Campbell RC, Irwin MG. The ASA Physical Status Classification: inter-observer consistency. American Society of Anesthesiologists. Anaesth Intensive Care 2002;30:633-40.
27. Heldwein W, Dollhopf M, Rosch T, et al. The Munich Polypectomy Study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomies. Endoscopy 2005;37:1116-22. (Pubitemid 41576669)
28. Ko CW, Riffle S, Michaels L, et al. Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol 2010;8:166-73.
29. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-50. (Pubitemid 8200494)
30. Detsky AS, Abrams HB, Forbath N, et al. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med 1986;146:2131-4.
31. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9. (Pubitemid 29416229)
32. Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110:859-66. (Pubitemid 19153770)
33. Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 1996;27:910-48.
34. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002;39:542-53.
35. Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989;64:651-4. (Pubitemid 19230238)
36. Riddell JW, Chiche L, Plaud B, et al. Coronary stents and noncardiac surgery. Circulation 2007;116:e378-82.
37. Kwok A, Faigel DO. Management of anticoagulation before and after gastrointestinal endoscopy.AmJ Gastroenterol 2009;104:3085-97; quiz 3098.
38. Veitch AM, Baglin TP, Gershlick AH, et al. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 2008;57:1322-9.
39. Zuckerman MJ, Hirota WK, Adler DG, et al. ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointest Endosc 2005;61:189-94. (Pubitemid 40261064)